CARGO Therapeutics (CRGX) Competitors

uniQure (NASDAQ:QURE) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings.

Do analysts rate QURE or CRGX?

uniQure currently has a consensus price target of $37.45, suggesting a potential upside of 118.70%. CARGO Therapeutics has a consensus price target of $15.40, suggesting a potential upside of 244.52%. Given CARGO Therapeutics' higher possible upside, analysts plainly believe CARGO Therapeutics is more favorable than uniQure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
uniQure	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.00
CARGO Therapeutics	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

Does the media prefer QURE or CRGX?

In the previous week, uniQure and uniQure both had 2 articles in the media. uniQure's average media sentiment score of 0.00 equaled CARGO Therapeutics'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
uniQure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CARGO Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals and insiders have more ownership in QURE or CRGX?

78.8% of uniQure shares are held by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are held by institutional investors. 4.8% of uniQure shares are held by company insiders. Comparatively, 2.9% of CARGO Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has more volatility and risk, QURE or CRGX?

uniQure has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500.

Which has preferable earnings and valuation, QURE or CRGX?

CARGO Therapeutics has lower revenue, but higher earnings than uniQure. uniQure is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
uniQure	$27.12M	34.65	-$239.56M	-$3.92	-4.37
CARGO Therapeutics	N/A	N/A	-$167.50M	-$4.64	-0.96

Is QURE or CRGX more profitable?

CARGO Therapeutics has a net margin of 0.00% compared to uniQure's net margin of -1,387.98%. CARGO Therapeutics' return on equity of -43.21% beat uniQure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
uniQure	-1,387.98%	-1,010.74%	-33.27%
CARGO Therapeutics	N/A	-43.21%	-37.26%

Summary

uniQure and CARGO Therapeutics tied by winning 7 of the 14 factors compared between the two stocks.